We revealed that although knockdown of SBF2-AS1 repressed the growth and aggressive traits of NSCLC cell, miRNA-338-3p inhibitor reversed the effects of SBF2-AS1-specific siRNA. The gene discussed is SBF2; the disease is non-small cell lung carcinoma.